jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Review

Advancing Breast Cancer: Strategies to Counteract Taxane Resistance in Her2-Positive and Triple-Negative Breast Cancer

Deepak Thakre1, Priyanka Singanwad2, Milind Umekar3, Amol Tatode3★, Nishant Awandekar1, Mohammad Qutub3, Ujban Mohammad Hussain4★ Corresponding author

  1. 1Department of Industrial Pharmacy, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, RTMNU, Nagpur, Maharashtra, INDIA.
  2. 2Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, RTMNU, Nagpur, Maharashtra, INDIA.
  3. 3Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, RTMNU, Nagpur, Maharashtra, INDIA.
  4. 4Department of Pharmaceutics, Department of Pharmaceutical Sciences, RTMNU, Nagpur, Maharashtra, INDIA.

CORRESPONDENCE

Amol Tatode

Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, RTMNU, Nagpur, Maharashtra, INDIA.

aatatode@gmail.com

Received: 09-05-2026; Revised: 18-06-2026; Accepted: 29-08-2026.

Volume 60, Issue 4S · pp. s1364–s1373 · PUBLISHED 2026 · DOI: 10.5530/ijper.20261755

View on IJPER original site ↗

ABSTRACT

Resistance is one of the major problems in chemotherapy during Breast Cancer (BC) treatment. Earlier treatments, such as radiation, surgery, and chemotherapy including taxane-based therapies like paclitaxel and docetaxel, play a crucial role in managing BC, particularly in aggressive subtypes like Human Epidermal Growth Factor Receptor-2 (HER-2) positive and Triple-Negative Breast Cancer (TNBC). Taxanes disrupt cell division by stabilizing microtubules, inducing apoptosis in rapidly dividing cancer cells. However, challenges arise due to drug resistance mechanisms, including alterations in microtubule dynamics, drug efflux, mutations in tubulin, Autophagy and survival pathway activation. Recent advancements in nanotechnology, such as nanoparticle-based drug delivery systems, have shown effect result in improving solubility, stability, and tumor selectivity, enhancing their therapeutic efficacy. By enabling targeted therapy, combination therapy and overcoming multidrug resistance, nanomedicine offers a promising approach to improve outcomes in resistant BC cases. This review examines the mechanisms of action of taxanes and resistance caused and discusses the role of various therapeutic strategies to overcoming treatment barriers in BC.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Thakre, D., Singanwad, P., Umekar, M., Tatode, A., Awandekar, N., Qutub, M., & Hussain, U. M. (2026). Advancing Breast Cancer: Strategies to Counteract Taxane Resistance in Her2-Positive and Triple-Negative Breast Cancer. Indian Journal of Pharmaceutical Education and Research, 60(4S), s1364–s1373. https://doi.org/10.5530/ijper.20261755